The American Epilepsy Society's (AES) 72nd Annual Meeting convened on November 30 to December 4, 2018. At the meeting, AES promotes both basic and clinical research at the vanguard of diagnosing, treating, and curing epilepsy offering high-quality educational content across diverse work settings, professional roles, and experience levels.
The Director of the Epilepsy Division at Mayo Clinic in Phoenix discussed the issue of driving when withdrawing patients off seizure medication either because of treatment, remission or surgical intervention.
The SVP and chief strategy and development officer at Aquestive Therapeutics discussed the hope to provide both patients and providers with a more favorable, and still efficacious, option for seizure clusters.
The section chief of pediatric neurology at Nationwide Children’s Hospital and an associate professor of clinical pediatrics and neurology at The Ohio State University College of Medicine spoke about what the findings mean for patients.